One number that circulates: "21 days at room temperature for retatrutide." That figure refers to the factory-filled pen formulation, not a pharmacist-compounded vial
If the waist is shrinking while strength holds steady, the change is more likely to be useful
And in some people, the intestinal transit actually becomes irregular or accelerated as a compensatory response, leading to loose stools or outright diarrhea
The Therapeutic Goods Administration's (TGA) warning covers the following glucagon-like peptide-1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and obesity: Semaglutide, sold as Ozempic, Wegovy Tirzepatide, sold as Mounjaro Dulaglutide, sold as Trulicity Liraglutide, sold as Saxenda The TGA said the products had the potential to cause an eye disorder called non-arteritic anterior ischaemic optic neuropathy (NAION)
More serious is the possibility of accelerated cell growth